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Title  
The challenge of ageing populations and frail people:  can primary care adapt? 
Standfirst 
Health care systems worldwide are having to adapt to ageing populations and increasing numbers of 
older people with frailty with complex health and social needs, and in the UK primary care is at the 
frontline of policy attempts to meet this challenge, but achieving the goal of making frailty an 
integral part of primary care practice is not without considerable challenges. 
Introduction 
Healthcare systems worldwide are challenged to meet the needs of increasingly ageing populations, 
characterised more by multimorbidity and declining physical and mental function than by the 
individual acute diseases for which these systems were originally designed.1 Especially problematic is 
increasing numbers of frail elderly people; a condition characterised by age-related decline across 
multiple physiological systems,2 resulting in high vulnerability to adverse health outcomes, including 
dependency, need for long-term care and mortality.3  
Responding to these challenges, healthcare policy in the UK and many other countries4, has 
increased its focus on the complex interplay between the multiple health problems frequently 
encountered in older people, and the need to develop integrated and multidisciplinary health and 
social services. In the UK National Health Service (NHS), primary care is mainly delivered by General 
Practitioners (GP or family doctor) as medical generalists, who also act as gatekeepers to specialist 
service providers. Primary care is typically the first point of contact for NHS patients – the vast 
majority of the population - and thus is seen as the natural hub for much of this integrated activity. 
The great majority of GPs work in group practices of several GPs supported by ancillary medical and 
administrative staff, with practices themselves organised into Clinical Commissioning Groups (CCGs) 
responsible for the planning and commissioning of local health care services. Although practices are 
independent contractors, almost all practice funding comes from the UK Government through the 
General Medical Services (GMS) contractual arrangement. 
The UK primary care model, with its emphasis on holistic care and centralised policy levers, would 
appear well-suited to the adaptions needed to meet the changing health care needs of an ageing 
population. In this context the 2017 GMS contract for England introduced a new requirement for 
general practices to identify and appropriately manage all patients aged 65 or over with moderate or 
severe frailty.5 This development echoes expanding international activity around primary care-based 
frailty screening and assessment, using a wide variety of frailty measures6, foremost in Canada7, 
Europe8 and Scandinavia.9 However, to the best of our knowledge the UK is first to implement frailty 
screening and stratification at the national policy level, although previously the Netherlands 
conducted a four-year national research programme into improving frailty care.10  
Under the UK contract changes, all patients identified with severe frailty should receive annual falls 
and medication reviews and appropriate interventions provided (Box 1). Practices are also 
encouraged to “go further” by organising comprehensive geriatric assessments and personalised 
care planning where appropriate.11 The long-term goal is to establish frailty assessment as an 
integral part of routine primary care practice and improve the ability of GPs to organise high quality 
care for their more complex older patients, both within primary care and in collaboration with other 
services. The British Medical  Association has tried to reassure GPs that the work around frailty will 
not increase overall bureaucratic burden and will not undermine professional autonomy in the 
management of frail patients.12 Further, the National Institute for Health and Care Excellence (NICE) 
has proposed that increased costs from longer appointments, training and treatment optimisation 
will be offset by factors such as fewer unnecessary appointments, prescriptions and unplanned 
admissions.13 
Box 1: 2017/18 GMS contract change on the identification and management of frailty. Text from the 
official contract outcomes letter from the NHS Medical Directorate to all primary care providers 
 
 
However, successful implementation of this agenda has important challenges, including the 
acceptability to primary care professionals and patients of frailty as a relevant concept, robust and 
efficient assessment of patient frailty, effective use of that information to improve care planning and 
patient outcomes, and convincing already over-stretched14 primary care professionals that this 
approach will ultimately reduce, or at least not increase, their workloads. 
Prevalence of frailty in the UK 
Estimated prevalence rates of frailty in the population vary widely depending upon the measure 
used.15 For GMS contract purposes NHS England uses estimates based on the electronic Frailty Index 
(eFI)16 and the ResearchOne database, suggesting that 3% of people 65 and older are severely frail, 
and another 12% moderately frail.16 Replicating this in the Clinical Practice Research Datalink (CPRD) 
primary care database, we found similar rates: 2.7% and 10.2% respectively (Table 1). Based on this, 
the average GP practice of 7,000 patients, will have around 30 severely and 100 moderately frail 
patients.  
Practices will use an appropriate tool, e.g. Electronic Frailty Index (eFI) to identify patients aged 
65 and over who are living with moderate and severe frailty. For those patients identified as 
living with severe frailty, the practice will deliver a clinical review providing an annual medication 
review and where clinically appropriate discuss whether the patient has fallen in the last 12 
months and provide any other clinically relevant interventions. In addition, where a patient does 
not already have an enriched Summary Care Record (SCR) the practice will promote this by 
seeking informed patient consent to activate the enriched SCR. 
Practices will code clinical interventions for this group appropriately. Data will be collected on 
the number of patients recorded with a diagnosis of moderate frailty, the number of patients 
with severe frailty, the number of patients with severe frailty with an annual medication review, 
the number of patients with severe frailty who are recorded as having had a fall in the preceding 
12 months and the number of severely frail patients who provided explicit consent to activate 
their enriched SCR. NHS England will use this information to understand the nature of the 
interventions made and the prevalence of frailty by degree among practice populations and 
nationally. This data will not be used for performance management purposes or benchmarking 
purposes. 
Table 1: Frailty categories and prevalence rates in people aged 65 to 95 on 1st January 2015, from 
analysis of the Clinical Practice Research Datalink 
Frailty category eFI score range Prevalence (on 1
st Jan 2015) 
n % 
Fit 0-0.12 591,527 61.3 
Mild >0.12-0.24 248,986 25.8 
Moderate >0.24-0.36 98,096 10.2 
Severe >0.36 25,877 2.7 
 
Challenges to the adoption of the frailty agenda in primary care 
Acceptance of frailty as a relevant concept for primary care 
Frailty is not the only approach to targeting elderly patients with complex needs. Frailty replaced a 
previous initiative in the GMS contract focused on patients at risk of an unplanned hospital 
admission - highly unpopular with GPs for various reasons.12 Another advocated approach is to focus 
on multimorbidity - people with two or more chronic conditions - and NHS England has published 
guidelines for multimorbidity management in primary care.17 Overlap between these groups is less 
than one might expect: using ResearchOne, more than half the patients in the top 2% of eFI scores 
are in neither the top 2% of multimorbidity counts nor top 2% of unplanned admission risk. 
Nevertheless, implementing different schemes and guidelines for each group seems unduly complex 
and inefficient, especially as they share several core management elements (medicines review, 
personalised assessment, care planning). Around 27% of adults have multimorbidity,18 therefore 
additional factors, including frailty, risk for unplanned care or management complexity, should also 
be present,17 further blurring distinctions between the groups. Although frailty is the more complex 
concept, this approach does have a stronger theoretical basis related to its origins in geriatric 
medicine.19  
Frailty aligns well with the generalist perspective of primary care and can motivate a constructive 
dialogue between the primary care team, the patient and key carers around frailty-appropriate care 
and support needs. However, GPs may feel that they are already aware of their relevant patients 
and are meeting their needs, without labelling them frail. They may even view frailty as unnecessary 
medicalisation or over-simplification of a patient’s medical complexity.20 A frailty label also carries 
significant stigma for many people through association with loss of independence and end of life,21 
and can deter people from seeking support or make them fear being denied sought-after care.21 This 
can close discussion down, instead of opening it up. These challenges around the language of frailty 
will likely require a longer-term focus, but there are precedents in the evolution of public 
understanding and acceptance of diagnoses such as cancer or dementia. 
Frailty also focuses purely on health deficits, an approach criticised for under-valuing the role of 
cognitive, material and social capacities on an individual’s ability to manage their health and on 
clinical decisions about their care.22 Thus two equally frail people may have quite different access to 
social network support, or abilities to manage their treatment burdens. However, rather than 
making frailty identification irrelevant, this instead re-emphasises the importance of using frailty not 
as a label but as an opportunity for a holistic discussion around care needs and the support and 
services required, in the broadest possible sense - not only health but also personal, public, private, 
voluntary and community resources.23 The argument for placing frailty in this broader context has 
strong theoretical underpinnings in the cumulative complexity and minimally disruptive medicine 
literature.22 24 Although this goes well beyond what most GPs have traditionally seen as their role 
and what practices are currently set up to do, it would seem essential to the goal of providing the 
best possible personalised care.  
Identification of frail patients 
Frailty is a complex medical condition and identifying the appropriate individuals can be 
problematic. NHS England recommends a two-stage process: an initial screen followed by direct 
clinical verification. The eFI is suggested as an “appropriate tool” for screening use11 and generates a 
frailty rating (fit, mild, moderate or severe - Table 1) from a patient’s primary care electronic health 
record (EHR), based on the accumulation of up to 36 health ‘deficits’ (Box 2).  Now available in all 
general practices in England, the eFI can rapidly screen all registered patients using their health care 
records alone. The tool has demonstrated moderate to good discrimination for the outcomes of 
mortality, unplanned hospitalisation and nursing home admission.16  
Box 2: List of the 36 deficits making up the electronic Frailty Index 
Activity limitation 
Anaemia and haematinic deficiency 
Arthritis 
Atrial fibrillation 
Cerebrovascular disease 
Chronic kidney disease 
Diabetes 
Dizziness 
Dyspnoea 
Falls 
Foot problems 
Fragility fracture 
Hearing impairment 
Heart failure 
Heart value disease 
Housebound 
Hypertension 
Hypotension/syncope 
Ischaemic heart disease 
Memory and cognitive problems 
Mobility and transfer problems 
Osteoporosis 
Parkinsonism and tremor 
Peptic ulcer 
Peripheral vascular disease 
Polypharmacy 
Requirement for care 
Respiratory disease 
Skin ulcer 
Sleep disturbance 
Social vulnerability 
Thyroid disease 
Urinary incontinence 
Urinary system disease 
Visual impairment 
Weight loss and anorexia 
 
 
The accuracy of the initial screen will be a major factor in the overall efficiency of the identification 
process. Screening tools other than the eFI can be used, and may identify quite different sets of 
individuals,25 but no consensus exists on which performs best. However, most UK practices are using 
the eFI. Anecdotal reports from GP colleagues and early pilots of the eFI26, have indicated that 
whereas  classifications do not always correspond with subsequent clinical judgement, the degree of 
mismatch may be within acceptable limits.26  
Even so, improvements in screening accuracy could produce substantial efficiency gains. The eFI 
analyses a patient’s entire EHR, but the CPRD reveals a strong association with length of registration, 
implying under-estimation for short records (<10 years) and/or over-estimation for long records 
(Figure 1). All deficits are treated as non-resolvable, thus conditions recorded many years previously 
but not since, including some acute events such as UTIs, count towards the current frailty score. 
Hence criteria for the recency and frequency of codes might improve alignment with clinical 
diagnosis. Efficiencies might also be gained by introducing differential weighting of the included 
deficits and setting the thresholds for frailty more on clinical, rather than the current statistical, 
criteria. To these ends we are currently engaged in a study using a panel of GPs to evaluate 
modifications to the tool with the aim of improving its efficiency as a screening instrument.27  
Frailty and care management 
Accurate identification is important, but has little point unless it makes a difference to patients. The 
minimum contract requirement that all severely frail patients receive annual medication and falls 
reviews is arguably already expected under NHS quality standards.28 29 To have a transformative 
impact on patient care, practices will need to commit to “go further”. The main NHS England 
recommendation, depending upon individual need, is a brief comprehensive geriatric assessment 
(brief CGA) and personalised care plan11, with multidisciplinary CGA or less intensive GP-led “holistic 
medical review” where appropriate. The supporting evidence base, however, is not strong. A well-
conducted review of CGA in community-based people with multimorbidity found clinically important 
benefits for mortality and care home admissions, but limited impact on quality of life and no benefit 
for unscheduled care or functional outcomes,17 while an earlier meta-analysis of 24 trials of geriatric 
assessment of people selected as frail, reported a small effect on hospital admissions only.30 Three 
later randomised trials of CGA within the Netherland’s frailty care programme found almost no 
clinical benefits.31 Available evidence for cost-effectiveness is inconsistent and inconclusive.17 31 32 
However, most of this evidence is weak and NHS England recommends further research based on 
the potential benefits for some critical outcomes.17 Benefits may also be more certain for more 
resource-intensive interventions17 and for some patient sub-groups.30 Developing greater 
understanding of approaches that work and for whom, will nevertheless take considerable time. 
More immediately, finding ways to streamline frailty-related work would help. Examples are 
replacing condition-specific annual reviews by a single holistic review for those with severe frailty, 
and a primary care nursing role for frail people, as exists in some other countries and with which 
some UK services are experimenting.33 The expansion of clinical pharmacists within general practice 
teams and nursing homes can facilitate greater use of medication review, while more efficient 
means of delivering CGA and care planning could also help, such as geriatrician “outreach” clinics 
within primary care and involvement of carers and the voluntary sector in care planning.34 35 Utilising 
frailty information more directly in management decisions might also bring efficiencies.19 Adequate 
discussion is beyond the current article, but one example would be specific guidelines for sub-groups 
of frail older people, such as people with type 2 diabetes.36 Such initiatives may already be 
happening at local levels, but frailty could offer opportunities on a national scale. 
Conclusion 
The goal of making frailty an integral part of primary care practice provides opportunities for 
beneficial change but is not without considerable challenges (Box 3). Further developments can help 
overcome many current limitations and obstacles, but in the over-stretched UK primary care system, 
the acid test is likely to be whether GPs find that a focus on frailty helps to reduce, rather than 
increase, professional burden in dealing with their most complex patients, whilst also benefiting 
their older patients living with frailty.  
Box 3: Potential benefits and disadvantages of frailty in primary care 
 
Key Messages: 
Increasing numbers of frail older people are a major concern to health services worldwide, and in 
the UK primary care is at the frontline of policy attempts to meet this challenge, but achieving the 
goal of making frailty an integral part of primary care practice is not without considerable challenges. 
To be motivated to do more than just the minimum required under the new General Medical 
Services contract, GPs may need convincing that this will help to reduce, rather than increase, 
professional burden in dealing with complexity, whilst also benefiting their older patients living with 
frailty. 
Future developments should focus on increasing efficiencies in the identification of frail patients and 
in the planning and delivery of frailty-appropriate care, taking account of individual patient 
capacities and circumstances as well as frailty status. 
Contributors and sources 
Potential benefits 
• Help primary care professionals focus on managing the person as a whole rather than on 
care for single diseases  
• Provide an opportunity for constructive dialogue with patients and family/carers about 
care goals and the services required, in the broadest sense.  
• Improve co-ordination of care and outcomes for older people living with frailty 
• Help reduce professional burden in dealing with complex patients 
• Decrease treatment burden for patients and unnecessary or harmful testing and 
medication 
• Help distinguish patients who are more, and less, likely to benefit from specific 
interventions, regardless of age. 
• Help identify those at risk of increasing frailty and offer preventative programs 
Potential disadvantages 
• May increase practice workload without adequate compensatory benefits 
• May not produce the anticipated improvements in clinical outcomes or quality of life for 
patients 
• May be viewed as over-medicalisation and over-simplification of complex problems 
• Negative connotations to the label “frail” may undermine acceptance and interfere with 
the care planning process 
• By itself does not take into account a patient’s personal and social capacities 
• More efficient means are needed for robustly identifying frail patients and for planning 
and delivering frailty-appropriate care 
The idea for this article originated from an ongoing research programme around patient frailty. HvM 
and TB are academic GPs experiencing first-hand the implementation of the frailty agenda in their 
practices. AC is a Consultant Geriatrician who led the original development of the eFI and was 
involved in the planning of the frailty element of the new GMS contract. DR is PI on an ongoing study 
to improve the current electronic Frailty Index, on which SP leads the statistical analysis. DR, SP, 
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